Premier Biomedical, Inc.
BIEI
Rank in Stocks
#32669
Premier Biomedical, Inc., a research-based company, discovers and develops... Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Share Price
$0.0008
Last synced: 2026-11-09
Market Cap
$1.32M
Change (1 day)
14.29%
Change (1 year)
33.33%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Premier Biomedical, Inc. (BIEI)
Category
Healthcare
EPS for Premier Biomedical, Inc. (BIEI)
EPS as of June 2026 TTM: 0.00
According to Premier Biomedical, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Premier Biomedical, Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 0.00 | -50.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | -100.00% |
| 2020 | 0.00 | -92.96% |
| 2019 | $-0.01 | -93.55% |
| 2018 | $-0.11 | -94.27% |
| 2017 | $-1.92 | -99.69% |
| 2016 | $-625.00 | 2,926.63% |
| 2015 | $-20.65 | 18.00% |
| 2014 | $-17.50 | -77.42% |
| 2013 | $-77.50 | 113.38% |
| 2012 | $-36.32 | 1,358.63% |
| 2011 | $-2.49 | 99,500.00% |
| 2010 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | - |
US
|
|
| $1.93 | - |
SE
|
|
| $6.91 | - |
FR
|
|
| $0.02 | - |
HK
|
|
| $2.71 | - |
IT
|
Questions about Premier Biomedical, Inc.'s earnings per share (EPS)
What was Premier Biomedical, Inc.'s earnings per share (EPS) in 2025?
In 2025, Premier Biomedical, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Premier Biomedical, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Premier Biomedical, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Premier Biomedical, Inc.'s earnings per share (EPS) compare with similar companies?
Premier Biomedical, Inc.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.